ArticleiScience2026
Association between immune cells and multiple cancers: Insights from Mendelian randomization and gene-based analysis.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the roles of immune cells in cancer, we conducted Mendelian randomization (MR) analyses of 731 immune cells and 16 site-specific cancers, alongside gene-based and enrichment analyses. MR identified 79 significant associations (46 protective, 33 risk-enhancing). Key findings include BAFF-R on B cells lowering melanoma risk, and CD27 on B cells increasing lung cancer risk. Associations were also observed with breast, ovarian, cervical, and other cancers, but no significant association was found with oral cavity or pancreatic cancers. Gene-based analysis revealed 61 shared genes between immune cells and cancers. 56 genes were associated with prostate cancer, 30 with lung cancer, three with breast cancer, two with cervical cancer, and one with melanoma. Interestingly, several prostate cancer-associated genes were also associated with breast, cervical, and lung cancers. These findings suggest potential biological mechanisms linking immune cells to cancer development and progression, highlighting the complex role of the immune system in cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.